Skip to content
← Full study record

NCT00462605 · MORE INFO

Limitations, agreements, and source contact

MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia · Source last updated 2017-07-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
smithdo@jhmi.edu
organization
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
phone
410-614-5068
title
B. Douglas Smith
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
smithdo@jhmi.edu
organization
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
phone
410-614-5068
title
B. Douglas Smith

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice